143 related articles for article (PubMed ID: 20157248)
1. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R
J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248
[TBL] [Abstract][Full Text] [Related]
2. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
Zahn R; Juengling F; Bubrowski P; Jost E; Dykierek P; Talazko J; Huell M
Psychiatry Res; 2004 Dec; 132(2):159-72. PubMed ID: 15598550
[TBL] [Abstract][Full Text] [Related]
3. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
Kim EJ; Cho SS; Jeong Y; Park KC; Kang SJ; Kang E; Kim SE; Lee KH; Na DL
Brain; 2005 Aug; 128(Pt 8):1790-801. PubMed ID: 15888536
[TBL] [Abstract][Full Text] [Related]
4. Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography.
Zahn R; Buechert M; Overmans J; Talazko J; Specht K; Ko CW; Thiel T; Kaufmann R; Dykierek P; Juengling F; Hüll M
Psychiatry Res; 2005 Nov; 140(2):115-31. PubMed ID: 16253483
[TBL] [Abstract][Full Text] [Related]
5. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
[TBL] [Abstract][Full Text] [Related]
6. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
7. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
Anchisi D; Borroni B; Franceschi M; Kerrouche N; Kalbe E; Beuthien-Beumann B; Cappa S; Lenz O; Ludecke S; Marcone A; Mielke R; Ortelli P; Padovani A; Pelati O; Pupi A; Scarpini E; Weisenbach S; Herholz K; Salmon E; Holthoff V; Sorbi S; Fazio F; Perani D
Arch Neurol; 2005 Nov; 62(11):1728-33. PubMed ID: 16286547
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
10. Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
Del Sole A; Clerici F; Chiti A; Lecchi M; Mariani C; Maggiore L; Mosconi L; Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1357-66. PubMed ID: 18418593
[TBL] [Abstract][Full Text] [Related]
11. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
[TBL] [Abstract][Full Text] [Related]
12. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
[TBL] [Abstract][Full Text] [Related]
13. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
[TBL] [Abstract][Full Text] [Related]
14. FDG PET imaging in patients with pathologically verified dementia.
Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
[TBL] [Abstract][Full Text] [Related]
16. Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.
Takahashi R; Ishii K; Senda M; Ito K; Ishii K; Kato T; Makishi Y; Nishio T; Ikari Y; Iwatsubo T;
Ann Nucl Med; 2013 Jun; 27(5):452-9. PubMed ID: 23483370
[TBL] [Abstract][Full Text] [Related]
17. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.
Ishii K; Sasaki H; Kono AK; Miyamoto N; Fukuda T; Mori E
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):959-63. PubMed ID: 15800784
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease.
Fukumitsu N; Ishii K; Kimura Y; Oda K; Hashimoto M; Suzuki M; Ishiwata K
Ann Nucl Med; 2008 Dec; 22(10):841-7. PubMed ID: 19142702
[TBL] [Abstract][Full Text] [Related]
20. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
Kerrouche N; Herholz K; Mielke R; Holthoff V; Baron JC
J Cereb Blood Flow Metab; 2006 Sep; 26(9):1213-21. PubMed ID: 16525414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
